IL33 and infection: In a subsequent effort to modulate the trTreg response in vivo during acute infection, and considering the results from the previous section indicating that the Th1 responses emerging during infection may limit trTreg expansion, we opted to treat INF mice with IL-33 on 0, 3, and 6 dpi (Fig 5A).